The CDC Pittsburgh (National Center for Emerging and Zoonotic Infectious Diseases / Division of Integrated Disease Surveillance and Response) awarded a single-award Indefinite Delivery Contract to Verily Life Sciences LLC on September 29, 2026, with a ceiling of $145 million and ultimate completion date of September 27, 2031.
The contract procures scalable wastewater surveillance capabilities to detect routine and emerging infectious disease pathogens across multiple jurisdictions. The CDC intends to develop and implement wastewater surveillance systems that adapt to newly identified pathogens, with technical scope encompassing scalability of surveillance systems, detection methodologies, data integration capabilities, and implementation across diverse wastewater treatment facilities.
The contract emerged from pre-solicitation RFQ 75D301-26-R-73475, posted July 1, 2026, with a capability statement deadline of July 22, 2026. No set-aside applies. Place of performance is not specified in the source. Work is intended to support the CDC's public health infrastructure modernization effort under Executive Order 14398, leveraging contractor expertise in collecting and activating health data for federal disease surveillance programs.